Key to beating colorectal cancer hiding in plain sight?

(Osaka University) Colorectal cancer, one of the most common cancers in the developed world, is intrinsically resistant to many drug therapies. In an attempt to identify novel treatment strategies, researchers led by Osaka University examined the contribution of serine racemase (SRR) to colorectal cancer metabolism. In a world first, the researchers showed that SRR is required for cancer cell proliferation, and that inhibition of SRR in mice halted tumor progression, paving the way for future drug development.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news